Skip to content Skip to footer

Related content

The CNP analogue vosoritide reduces arrhythmia in diabetic cardiomyopathy via cGMP-dependent PDE2 stimulation on cellular and organ level

Firneburg, R., Tergau, K., Cachorro Puente, E., El-Armouche, A. & Radicke, S., 28 Oct 2024, In: European Heart Journal. 45, Suppl 1, ehae666.3773.

Research output: Contribution to journal › Meeting abstract › Contributed › peer-review

Antiarrhythmic effects of the CNP analogue vosoritide via the PDE2 mediated cGMP/cAMP Crosstalk in diabetic cardiomyopathy

Tergau, K., Firneburg, R., Cachorro Puente, E., Radicke, S. & El-Armouche, A., 11 Sept 2024, In: Clinical Research in Cardiology. 113, 10, p. 1514 1 p., 1514.

Research output: Contribution to journal › Meeting abstract › Contributed › peer-review

C-type natriuretic peptide and vericiguat reduce proarrhythmic Ca2+ signals via PDE2 in heart failure

Kocas, K., Firneburg, R., Cachorro Puente, E., El-Armouche, A. & Radicke, S., 11 Sept 2024, In: Clinical Research in Cardiology. 113, 10, p. 1514 1 p., 1514.

Research output: Contribution to journal › Meeting abstract › Contributed › peer-review

The cGMP-induced PDE2 stimulation as a novel antiarrhythmic strategy

Tergau, K., Gröner, M., Firneburg, R., Cachorro Puente, E., Günscht, M., Kocas, K. & Richter, C. & 2 others, El-Armouche, A. & Radicke, S., 25 Mar 2024, In: cGMP: Generators, Effectors and Therapeutic Implications Conference.

Research output: Contribution to journal › Meeting abstract › Invited › peer-review

cGMP-dependent PDE2 activation as a potential anti-arrhythmic therapy strategy in heart failure

Firneburg, R., Gröner, M., Günscht, M., Berning, H., Cachorro Puente, E., El-Armouche, A. & Radicke, S., 14 Mar 2024.

Research output: Contribution to conferences › Poster › Contributed › peer-review

View all research output (9)